Wird geladen...

Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension

BACKGROUND: β-Blocker therapy has been shown to improve survival among patients with ischaemic heart disease (IHD) and congestive heart failure (CHF) and is underused among patients with chronic obstructive pulmonary disease (COPD). Evidence regarding the optimal use of β-blocker therapy during an a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax
Hauptverfasser: Stefan, Mihaela S, Rothberg, Michael B, Priya, Aruna, Pekow, Penelope S, Au, David H, Lindenauer, Peter K
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454610/
https://ncbi.nlm.nih.gov/pubmed/22941975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2012-201945
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!